| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P2093 | author name string | Jian Li | |
| Feng Lin | |||
| Lunxu Liu | |||
| Yongsheng Zhao | |||
| Renyan Zheng | |||
| P2860 | cites work | Breast cancer susceptibility gene 1 (BRCA1) predict clinical outcome in platinum- and toxal-based chemotherapy in non-small-cell lung cancer (NSCLC) patients: a system review and meta-analysis | Q21198839 |
| Global cancer statistics | Q22241238 | ||
| TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta | Q24310394 | ||
| Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN | Q24322051 | ||
| Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints | Q27860640 | ||
| Operating characteristics of a rank correlation test for publication bias | Q27860653 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860749 | ||
| PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
| Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 | ||
| PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway | Q28139300 | ||
| Loss of PTEN facilitates HIF-1-mediated gene expression | Q28145476 | ||
| PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model | Q28202775 | ||
| Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Q28306997 | ||
| Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN | Q28513537 | ||
| PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway | Q28588309 | ||
| The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway | Q33599964 | ||
| A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen-activated protein kinases by epidermal growth factor. | Q33929512 | ||
| Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study | Q33969308 | ||
| PTEN and Ki67 expression is associated with clinicopathologic features of non-small cell lung cancer | Q34606601 | ||
| Prognostic value of the expression of phosphatase and tensin homolog and CD44 in elderly patients with refractory acute myeloid leukemia | Q35803001 | ||
| Prognostic Significance of mTOR and PTEN in Patients with Esophageal Squamous Cell Carcinoma | Q36013408 | ||
| Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancer | Q36285667 | ||
| Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis | Q36384467 | ||
| High-expression of DJ-1 and loss of PTEN associated with tumor metastasis and correlated with poor prognosis of gastric carcinoma | Q37249335 | ||
| PTEN: a new guardian of the genome. | Q37270432 | ||
| Worldwide Overview of the Current Status of Lung Cancer Diagnosis and Treatment | Q38063540 | ||
| PTEN. | Q38218236 | ||
| Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis | Q40679766 | ||
| Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer | Q40903462 | ||
| Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer. | Q40931689 | ||
| High levels of phosphatase and tensin homolog expression predict favorable prognosis in patients with non-small cell lung cancer | Q41593058 | ||
| Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer. | Q43222717 | ||
| Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN. | Q43297266 | ||
| Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer | Q43578829 | ||
| PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patients. | Q44846498 | ||
| Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis | Q47680928 | ||
| Alteration of the E-cadherin/β-catenin complex predicts poor response to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment | Q51072877 | ||
| Expression of FAK and PTEN in bronchioloalveolar carcinoma and lung adenocarcinoma | Q51799708 | ||
| Immunohistochemical characterization of the mTOR pathway in stage-I non-small-cell lung carcinoma | Q53220076 | ||
| Histologic-type specific role of cell cycle regulators in non-small cell lung carcinoma | Q53376865 | ||
| Expression and clinical evidence of miR-494 and PTEN in non-small cell lung cancer | Q53550499 | ||
| Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma. | Q54483370 | ||
| Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer | Q54502976 | ||
| Expression of the Mammalian Target of Rapamycin Pathway Markers in Lung Adenocarcinoma and Squamous Cell Carcinoma | Q54533454 | ||
| mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry | Q54546623 | ||
| PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small cell lung cancer | Q79889036 | ||
| Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas | Q79911245 | ||
| The prognostic value of osteopontin expression in non-small cell lung cancer: a meta-analysis | Q87851600 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 203-213 | |
| P577 | publication date | 2017-03-06 | |
| P1433 | published in | Thoracic Cancer | Q26842004 |
| P1476 | title | Loss of phosphatase and tensin homolog expression correlates with clinicopathological features of non-small cell lung cancer patients and its impact on survival: A systematic review and meta-analysis | |
| P478 | volume | 8 |
| Q58122535 | Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis |
| Q58788315 | Pectolinarigenin inhibits non‑small cell lung cancer progression by regulating the PTEN/PI3K/AKT signaling pathway |
| Q47620321 | The Smad4/PTEN Expression Pattern Predicts Clinical Outcomes in Colorectal Adenocarcinoma |
Search more.